Brief: Inova Schar Cancer Adopts Immunovia’S Pancreasure Test For Its High-Risk Surveillance Program
15/09/2025 07:06
Sept 15 (Reuters) - Immunovia AB (publ) IMMNOV.ST: INOVA SCHAR CANCER ADOPTS IMMUNOVIA’S PANCREASURE TEST FOR ITS HIGH-RISK SURVEILLANCE PROGRAM Source text: ID:nMFNbHvqgS Further company coverage: IMMNOV.ST (Gdansk Newsroom) ((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))